Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

Report Details

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 - your guide to developments, opportunities and revenues

Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain's brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024.

Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with historical data, recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments (R&D). Discover qualitative analyses (SWOT and STEP), company profiles and commercial developments. You also receive two interviews, and 90 tables, figures and charts

You will find prospects for key technology submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five technology submarkets to 2024:
• RFID (radio frequency identification)
• Security printing
• Taggants
• Holograms/OVD (optical variable devices)
• Other pharma anti-counterfeiting technologies

Our investigation shows business research and analysis with individual revenue forecasts and discussions.

Prospects for leading countries are shown to 2024

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. Growth in this market will be fuelled by government mandates requiring serialisation solutions on products.

You discover individual revenue forecasts to 2024 for these geographical markets:
• US
• Japan
• Germany, France, UK, Italy and Spain (EU5 Countries, as a group)
• Brazil
• Russia
• India
• China
• RoW

The expected launch of new technologies from 2013 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market.

Companies and overall 2016 market revenue - what predicted growth?

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions.

Our work profiles leading companies, assessing their technologies and products. You will see which technologies and organisations hold greatest potential.

In particular, we profile these leading organisations:
• 3M
• Authentix
• Alien Technology
• Colorcon
• NanoGuardian
• Thermo Scientific
• Angstrom Technologies
• AlpVision
• Avery Dennison
• Chesapeake
• Covectra
• Everest Holovisions
• InkSure Technologies
• Covectra
• Intermec
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You will find discussions of many issues and developments, including R&D:
• Parallel trade of medical products
• Activities of trade bodies and governmental organisations
• Security and efficiency of the pharma supply chain
• Wholesalers and other pharma intermediaries
• Actions taken by pharma companies
• Trading channels and drug counterfeiters
• Standards, regulations and policies

You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Our investigation gives you multi-level business research and analysis with sales forecasts. You will see how the industry and ma
1. Executive Summary

1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies

2. Introduction to Pharmaceutical Counterfeiting

2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Counterfeiting Incidents in Developed Regions
2.2 The Most Commonly Counterfeited Drugs
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs) Heparin Contamination Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.4.1 Methods of Producing Pharmaceutical Counterfeits
2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain
2.4.3 Corruption Within the Pharmaceutical Distribution System
2.5 The Internet and its Role in Pharmaceutical Counterfeiting
2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.5.3 Verifying the Authenticity of Online Pharmacies
2.6 Pharmaceutical Counterfeiting: The Global Costs
2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.6.2 The Impact of Counterfeiting on Healthcare Providers
2.6.3 The Impact of Counterfeiting on Pharma Manufacturers
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry Operation Pangea: Europol's Fight Against Counterfeiting Legislative Deficiencies Aiding Counterfeiting Operations
2.7 Factors Fuelling Pharmaceutical Counterfeiting
2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.7.3 Drug Misuse Creates a Market for Counterfeiting
2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.7.6 Counterfeiters Target Developed Markets
2.7.7 Parallel Trade - a Counterfeiting Route in Europe

3. Leading Technologies and Applications

3.1 Passive Technologies
3.1.1 Security Inks as Anti-counterfeiting Technologies
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.4 Overt and Hidden Imaging
3.2 Active Technologies
3.2.1 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
3.2.2 Taggants as Anti-counterfeiting Technologies
3.2.3 Mass Encoding Technology Digital Mass Serialisation Technology (DMS) Digital Mass Encryption (DME) Barcode Applications: Serialisation is Key

4. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market

4.1 3M: A Diversified Technology Multinational
4.2 Alien Technology: RFID Technology Specialist
4.3 AlpVision: Cryptoglyph Security Solution
4.3.1 Fingerprint: A 'Read Only' Technology
4.3.2 Krypsos Platform
4.3.3 Cryptoglyph
4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth
4.4 Angstrom Technologies - Security Inks
4.5 Authentix: Product Authentication and Brand Protection
4.5.1 Product-specific Track-and-Trace Solutions
4.5.2 Packaging Solutions
4.6 Avery Dennison: RFID Technologies Expert
4.7 Colorcon
4.7.1 Colorcon's Taggants: On-Dose ID
4.7.2 Colorcon's Brand Enhancement Service
4.8 Chesapeake: Acquired by The Caryle Group
4.9 Covectra
4.9.1 Covectra's Authenti-Track System for Product Tracing
4.9.2 Covec